ArticleFrontiers in medicine2025

Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin's effects on lipoprotein(a) and biochemical markers in hemodialysis patients.

Amira Reda Muhammad Galal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.